N. Al-Sakaff
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 26
- HER2/EGFR in Cancer Research 17
- Peptidase Inhibition and Analysis 6
- Colorectal Cancer Treatments and Studies 4
- Cancer Treatment and Pharmacology 3
-
- Gastric Cancer Management and Outcomes 6
- Advanced Breast Cancer Therapies 4
- Co-authors
- Sabine Lauer (6 shared papers)Evandro de Azambuja (2 shared papers)Martine Piccart (2 shared papers)Christian Jackisch (2 shared papers)Brian Leyland‐Jones (4 shared papers)David Cameron (3 shared papers)Mitch Dowsett (2 shared papers)Gilberto de Castro (2 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Annals of Oncology (5 papers)The Oncologist (3 papers)European Journal of Cancer (2 papers)Cancer Research (2 papers)
- Partner nations
- SwitzerlandSouth KoreaGermany
In The Last Decade
N. Al-Sakaff
26 papers receiving 1.2k citations
N. Al-Sakaff's Hit Papers
Peers
Comparison fields: 5 of 67
- Oncology 691
- Cancer Research 212
- Radiology, Nuclear Medicine and Imaging 226
- Cardiology and Cardiovascular Medicine 191
- Pulmonary and Respiratory Medicine 248
Countries citing papers authored by N. Al-Sakaff
This map shows the geographic impact of N. Al-Sakaff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Al-Sakaff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Al-Sakaff more than expected).
Fields of papers citing papers by N. Al-Sakaff
This network shows the impact of papers produced by N. Al-Sakaff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Al-Sakaff. The network helps show where N. Al-Sakaff may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Al-Sakaff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial Hit paper breakdown → | 2017 | 704 |
| 2 | 2009 | 114 | |
| 3 | 2017 | 109 | |
| 4 | 2019 | 58 | |
| 5 | 2023 | 45 | |
| 6 | 2014 | 36 | |
| 7 | 2009 | 28 | |
| 8 | 2013 | 24 | |
| 9 | 2018 | 22 | |
| 10 | 2019 | 12 | |
| 11 | 2018 | 12 | |
| 12 | 2016 | 8 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 6 | |
| 15 | 2020 | 6 | |
| 16 | 2012 | 6 | |
| 17 | 2018 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2011 | 4 | |
| 20 | 2015 | 2 |
About N. Al-Sakaff
N. Al-Sakaff is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Surgery, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (17 papers), Peptidase Inhibition and Analysis (6 papers), Gastric Cancer Management and Outcomes (6 papers), Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Oncology (691 citations), Cancer Research (212 citations), Radiology, Nuclear Medicine and Imaging (226 citations), Cardiology and Cardiovascular Medicine (191 citations) and Pulmonary and Respiratory Medicine (248 citations). N. Al-Sakaff has collaborated with scholars based in Switzerland, South Korea and Germany. Frequent co-authors include Sabine Lauer, Evandro de Azambuja, Martine Piccart, Christian Jackisch, Brian Leyland‐Jones, David Cameron, Mitch Dowsett, Gilberto de Castro, Aron Goldhirsch and Luca Gianni. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Oncologist, European Journal of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.